Delivery Order SPE2DB24D8002-SPE2DB25FJNBL

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,978.01 firm fixed-price contract is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to support U.S. Armed Forces medical operations. The contract has an ultimate completion date of November 5, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT...
This federal contract award, identified as SPE2DB24D8002|SPE2DB25FJMXP, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $13,373.39, is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of January 7, 2025. This award is not associated with a set-aside program. Dakota Drug, Inc....
This federal contract award, identified as SPE2DB24D8002 and SPE2DB25FJMMP, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc. The $6,236.68 firm fixed-price delivery order is for the provision of VEMLIDY 25 MG TABLET, a pharmaceutical product. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The company has significant experience supporting the DLA's medical supply...
Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation, has been awarded a firm fixed price delivery order valued at $6,195.56 by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical). Under this contract, Dakota Drug will provide 25 mg tablets of VEMLIDY, a medication used to treat hepatitis B virus infection, to Minot, North Dakota in quantities of 30 tablets per unit. No set-aside was designated for this...
Dakota Drug, Inc. was awarded a $4,506.20 firm fixed price delivery order against an unidentified contract vehicle by the Defense Logistics Agency Troop Support Medical to provide 4562474485 VEMLIDY 25 MG TABLET UU 30S by October 16, 2023. The delivery order was awarded on October 13, 2023 without a set-aside designation. Dakota Drug, Inc. will fulfill the order for the pharmaceutical product from its place of performance in Minot, North Dakota for the Defense Logistics Agency, which procures...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,738.12 contract is for the delivery of AREXVY VIAL KITS, with a period of performance through October 28, 2024. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, providing a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of the pharmaceutical product Viibryd 20 mg tablets, with a ceiling value of $1,309.00 and a period of performance through August 29, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of pharmaceutical products, medical supplies, and healthcare equipment. The contract has a ceiling value of $3,650.51 and is a firm fixed-price delivery order without a set-aside designation. Dakota Drug, Inc. is a key supplier for the DLA's Troop Support Medical division, delivering a wide range of medical items...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a small disadvantaged business. The contract, valued at $3,900.47, is for the delivery of Jardiance 10 mg tablets to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, to provide a comprehensive range of pharmaceutical products, medical supplies, and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products. The contract has a firm fixed price pricing type, a ceiling value of $4,822.96, and a period of performance through January 7, 2025. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, holding a single-award Indefinite Delivery...
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB25FJNBL
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,511.06 firm-fixed-price contract is for the delivery of VEMLIDY 25 MG TABLET in support of U.S. Armed Forces medical operations. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) that allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment. This delivery order is not a set-aside contract. The contract has an ultimate completion date of January 30, 2025.

Generated 4/30/25, 9:43 AM